* Merit Medical Systems Inc MMSI.OQ MMSI.O is expected
to show
a rise in quarterly revenue when it reports results
* The South Jordan Utah-based company is expected to report
a
6.6% increase in revenue to $306.271 million from $287.18
million a year ago, according to the mean estimate from 7
analysts, based on Refinitiv data. The company's guidance on
July 25 2023, for the period ended September 30, was for revenue
between 302.97 million and 308.71 million.
* Refinitiv's mean analyst estimate for Merit Medical
Systems Inc
is for earnings of 65 cents per share. The company's EPS
guidance on July 25 2023, for the period ended September 30, was
between 0.61 and 0.66
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Merit
Medical
Systems Inc is $92.5, above its last closing price of $65.29.
The company's guidance on July 25 2023 for the period ended
September 30 was for Earnings before Interest and Taxes between
50.29296 million and 52.78994 million.The company's guidance on
July 25 2023 for the period ended September 30 was for gross
profit margin between 50.3% and 50.6%.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2023 0.75 0.75 0.81 Beat 7.9
Mar. 31 2023 0.55 0.55 0.64 Beat 17.2
Dec. 31 2022 0.67 0.67 0.79 Beat 17.7
Sep. 30 2022 0.53 0.53 0.64 Beat 21.1
Jun. 0.58 0.58 0.73 Beat 26.3
30 2022
Mar. 31 2022 0.47 0.47 0.53 Beat 13.9
Dec. 31 2021 0.51 0.52 0.71 Beat 36.5
Sep. 30 2021 0.44 0.44 0.52 Beat 19.2
This summary was machine generated October 25 at 02:05 GMT. All
figures in US dollars unless otherwise stated